SUMMARYAlthough not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories.
The goal of AFST is to reliably produce MIC values that may be used to guide patient therapy, inform epidemiological studies, and track rates of antifungal drug resistance. There are three methods that have been standardized by standards development organizations: broth dilution, disk diffusion, and azole agar screening for Aspergillus Other commonly used methods include gradient diffusion and the use of rapid automated instruments.
Br-PEG7-Br |
|||
T17695-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Br-PEG7-Br |
Br-PEG7-Br |
|||
T17695-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Br-PEG7-Br |
Br-PEG7-Br |
|||
T17695-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Br-PEG7-Br |
Br-PEG7-Br |
|||
T17695-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Br-PEG7-Br |
Br-PEG7-Br |
|||
T17695-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Br-PEG7-Br |
Br-PEG-Br,10K |
|||
33-HO056056-10K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Br-PEG-Br,1K |
|||
33-HO056056-1K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Br-PEG-Br,20K |
|||
33-HO056056-20K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Br-PEG-Br,2K |
|||
33-HO056056-2K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Br-PEG-Br,3.4K |
|||
33-HO056056-3.4K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Br-PEG-Br,5K |
|||
33-HO056056-5K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br |
|||
abx085351-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 258 |
mPEG-Br |
|||
abx085351-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 286.8 |
mPEG-Br |
|||
abx085351-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 286.8 |
mPEG-Br |
|||
abx085412-075kDa1g | Abbexa | 0.75 kDa; 1 g | EUR 560.4 |
mPEG-Br |
|||
abx085412-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 526.8 |
mPEG9-Br |
|||
abx085415-1g | Abbexa | 1 g | EUR 777.6 |
Methylatropine Br |
|||
593048 | MedKoo Biosciences | 5.0mg | EUR 230 |
Dimidium Br |
|||
112001 | MedKoo Biosciences | 25.0mg | EUR 210 |
Dodecyltrimethylammonium Br |
|||
112166 | MedKoo Biosciences | 5.0g | EUR 230 |
Benzododecinium Br |
|||
464319 | MedKoo Biosciences | 25.0mg | Ask for price |
BR-1 |
|||
565034 | MedKoo Biosciences | 1.0mg | EUR 205 |
MPAC-Br |
|||
GW4614-10 | Glentham Life Sciences | 10 | EUR 110.8 |
MPAC-Br |
|||
GW4614-250 | Glentham Life Sciences | 250 | EUR 979.2 |
MPAC-Br |
|||
GW4614-50 | Glentham Life Sciences | 50 | EUR 311.9 |
Lenalidomide-Br |
|||
HY-43722 | MedChemExpress | 50mg | EUR 2332.8 |
Br-Mmc |
|||
T18927-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Br-Mmc |
Br-Mmc |
|||
T18927-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Br-Mmc |
Br-Mmc |
|||
T18927-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Br-Mmc |
Br-Mmc |
|||
T18927-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Br-Mmc |
Br-Mmc |
|||
T18927-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Br-Mmc |
Lenalidomide-Br |
|||
T18064-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Lenalidomide-Br |
Lenalidomide-Br |
|||
T18064-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Lenalidomide-Br |
Lenalidomide-Br |
|||
T18064-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Lenalidomide-Br |
Lenalidomide-Br |
|||
T18064-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Lenalidomide-Br |
Lenalidomide-Br |
|||
T18064-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Lenalidomide-Br |
Br-DAPI |
|||
T39967-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Br-DAPI |
Br-DAPI |
|||
T39967-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Br-DAPI |
Br-DAPI |
|||
T39967-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Br-DAPI |
Br-DAPI |
|||
T39967-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Br-DAPI |
Br-DAPI |
|||
T39967-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Br-DAPI |
Br-PBTC |
|||
T39286-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Br-PBTC |
Br-PBTC |
|||
T39286-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Br-PBTC |
Br-PBTC |
|||
T39286-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Br-PBTC |
Br-PBTC |
|||
T39286-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Br-PBTC |
Br-PBTC |
|||
T39286-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Br-PBTC |
MSX-122 |
|||
201961 | MedKoo Biosciences | 5.0mg | EUR 90 |
CC-122 |
|||
B1650-25 | Biovision | each | EUR 1149.6 |
CC-122 |
|||
B1650-5 | Biovision | each | EUR 366 |
MSX-122 |
|||
B2276-25 | Biovision | each | EUR 483.6 |
MSX-122 |
|||
B2276-5 | Biovision | each | EUR 170.4 |
NTE-122 |
|||
563381 | MedKoo Biosciences | 5.0mg | EUR 340 |
MSX-122 |
|||
HY-13696 | MedChemExpress | 50mg | EUR 639.6 |
NK-122 |
|||
T33697-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: NK-122 |
NK-122 |
|||
T33697-1g | TargetMol Chemicals | 1g | Ask for price |
Description: NK-122 |
NK-122 |
|||
T33697-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: NK-122 |
NK-122 |
|||
T33697-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: NK-122 |
NK-122 |
|||
T33697-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: NK-122 |
KNI 122 |
|||
T32408-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: KNI 122 |
KNI 122 |
|||
T32408-1g | TargetMol Chemicals | 1g | Ask for price |
Description: KNI 122 |
KNI 122 |
|||
T32408-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: KNI 122 |
KNI 122 |
|||
T32408-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: KNI 122 |
KNI 122 |
|||
T32408-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: KNI 122 |
NTE-122 |
|||
T25891-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: NTE-122 |
NTE-122 |
|||
T25891-1g | TargetMol Chemicals | 1g | Ask for price |
Description: NTE-122 |
NTE-122 |
|||
T25891-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: NTE-122 |
NTE-122 |
|||
T25891-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: NTE-122 |
NTE-122 |
|||
T25891-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: NTE-122 |
EO-122 |
|||
T27272-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EO-122 |
EO-122 |
|||
T27272-1g | TargetMol Chemicals | 1g | Ask for price |
Description: EO-122 |
EO-122 |
|||
T27272-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: EO-122 |
EO-122 |
|||
T27272-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: EO-122 |
EO-122 |
|||
T27272-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: EO-122 |
JK-122 |
|||
T27656-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: JK-122 |
JK-122 |
|||
T27656-1g | TargetMol Chemicals | 1g | Ask for price |
Description: JK-122 |
JK-122 |
|||
T27656-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: JK-122 |
JK-122 |
|||
T27656-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: JK-122 |
JK-122 |
|||
T27656-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: JK-122 |
MSX-122 |
|||
T3992-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: MSX-122 |
MSX-122 |
|||
T3992-1g | TargetMol Chemicals | 1g | Ask for price |
Description: MSX-122 |
MSX-122 |
|||
T3992-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: MSX-122 |
MSX-122 |
|||
T3992-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: MSX-122 |
MSX-122 |
|||
T3992-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: MSX-122 |
miRZip-122 anti-miR-122 microRNA construct |
|||
MZIP122-PA-1 | SBI | Bacterial Streak | EUR 620 |
Br-PEG-Mal |
|||
abx085167-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 1045.2 |
Br-PEG-Mal |
|||
abx085167-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 1045.2 |
Br-PEG-Mal |
|||
abx085167-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1045.2 |
QX-314 Br |
|||
532485 | MedKoo Biosciences | 25.0mg | EUR 180 |
SK-BR-3 |
|||
ABC-TC1026 | AcceGen | 1 vial | Ask for price |
Description: The SK-BR-3 cell line was derived from a pleural effusion due to an adenocarcinoma originating in the breast of a 43-year-old, caucasian female. The cell line over-expresses the HER2 gene product. |
8-Br-cAMP |
|||
1837-25 | Biovision | each | EUR 301.2 |
8-Br-cAMP |
|||
1837-5 | Biovision | each | EUR 144 |
8-Br-cGMP |
|||
1838-25 | Biovision | each | EUR 339.6 |
8-Br-cGMP |
|||
1838-5 | Biovision | each | EUR 164.4 |
5-Br-CTP |
|||
B8033-.01 | ApexBio | 10 µl (100 mM) | EUR 91 |
Description: Base modified ribonucleoside triphosphates |
5-Br-CTP |
|||
B8033-.05 | ApexBio | 50 µl (100 mM) | EUR 982 |
Description: Base modified ribonucleoside triphosphates |
5-Br-CTP |
|||
B8033-.1 | ApexBio | 100 µl (100 mM) | EUR 1747 |
Description: Base modified ribonucleoside triphosphates |
5-Br-UTP |
|||
B8034-.01 | ApexBio | 10 µl (100 mM) | EUR 75 |
Description: Base modified ribonucleoside triphosphates |
5-Br-UTP |
|||
B8034-.05 | ApexBio | 50 µl (100 mM) | EUR 363 |
Description: Base modified ribonucleoside triphosphates |
5-Br-UTP |
|||
B8034-.1 | ApexBio | 100 µl (100 mM) | EUR 592 |
Description: Base modified ribonucleoside triphosphates |
5-Br-dCTP |
|||
B8081-.01 | ApexBio | 10ul (100 mM) | EUR 58 |
5-Br-dCTP |
|||
B8081-.05 | ApexBio | 50ul (100 mM) | EUR 271 |
5-Br-dCTP |
|||
B8081-.1 | ApexBio | 100ul (100 mM) | EUR 466 |
5-Br-dUTP |
|||
B8082-.01 | ApexBio | 10ul (100 mM) | EUR 20 |
5-Br-dUTP |
|||
B8082-.05 | ApexBio | 50ul (100 mM) | EUR 86 |
5-Br-dUTP |
|||
B8082-.1 | ApexBio | 100ul (100 mM) | EUR 155 |
5-Br-ddUTP |
|||
B8295-.01 | ApexBio | 10ul (100 mM) | EUR 138 |
Description: Sugar modified nucleoside triphosphates |
5-Br-ddUTP |
|||
B8295-.05 | ApexBio | 50ul (100 mM) | EUR 658 |
Description: Sugar modified nucleoside triphosphates |
5-Br-ddUTP |
|||
B8295-.1 | ApexBio | 100ul (100 mM) | EUR 1208 |
Description: Sugar modified nucleoside triphosphates |
8-Br-cGMP |
|||
563397 | MedKoo Biosciences | 10.0mg | EUR 230 |
UCL-1684 Br |
|||
563563 | MedKoo Biosciences | 5.0mg | EUR 295 |
mPEG-Br,10K |
|||
33-MF001056-10K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br,1K |
|||
33-MF001056-1K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br,20K |
|||
33-MF001056-20K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br,2K |
|||
33-MF001056-2K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br,3.4K |
|||
33-MF001056-3.4K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
mPEG-Br,5K |
|||
33-MF001056-5K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Naphthol AS-BR |
|||
T30655-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Naphthol AS-BR |
Naphthol AS-BR |
|||
T30655-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Naphthol AS-BR |
Naphthol AS-BR |
|||
T30655-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Naphthol AS-BR |
Naphthol AS-BR |
|||
T30655-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Naphthol AS-BR |
Naphthol AS-BR |
|||
T30655-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Naphthol AS-BR |
m-PEG4-Br |
|||
T15872-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: m-PEG4-Br |
m-PEG4-Br |
|||
T15872-1g | TargetMol Chemicals | 1g | Ask for price |
Description: m-PEG4-Br |
m-PEG4-Br |
|||
T15872-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: m-PEG4-Br |
m-PEG4-Br |
|||
T15872-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: m-PEG4-Br |
m-PEG4-Br |
|||
T15872-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: m-PEG4-Br |
m-PEG5-Br |
|||
T15891-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: m-PEG5-Br |
m-PEG5-Br |
|||
T15891-1g | TargetMol Chemicals | 1g | Ask for price |
Description: m-PEG5-Br |
m-PEG5-Br |
|||
T15891-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: m-PEG5-Br |
m-PEG5-Br |
|||
T15891-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: m-PEG5-Br |
m-PEG5-Br |
|||
T15891-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: m-PEG5-Br |
m-PEG6-Br |
|||
T15909-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: m-PEG6-Br |
m-PEG6-Br |
|||
T15909-1g | TargetMol Chemicals | 1g | Ask for price |
Description: m-PEG6-Br |
m-PEG6-Br |
|||
T15909-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: m-PEG6-Br |
m-PEG6-Br |
|||
T15909-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: m-PEG6-Br |
m-PEG6-Br |
|||
T15909-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: m-PEG6-Br |
m-PEG8-Br |
|||
T15929-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: m-PEG8-Br |
m-PEG8-Br |
|||
T15929-1g | TargetMol Chemicals | 1g | Ask for price |
Description: m-PEG8-Br |
m-PEG8-Br |
|||
T15929-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: m-PEG8-Br |
m-PEG8-Br |
|||
T15929-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: m-PEG8-Br |
m-PEG8-Br |
|||
T15929-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: m-PEG8-Br |
Propargyl-PEG4-Br |
|||
T16619-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Propargyl-PEG4-Br |
Propargyl-PEG4-Br |
|||
T16619-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Propargyl-PEG4-Br |
Propargyl-PEG4-Br |
|||
T16619-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Propargyl-PEG4-Br |
Novel methodologies for susceptibility testing are in development. It is important for laboratories to consider not only the method of testing but also the interpretation (or lack thereof) of in vitro data.